As of Wednesday close, Tenax Therapeutics Inc.’s (NASDAQ:TENX) stock was up $0.02, moving up 11.29 percent to $0.14. The average number of shares traded per day over the past five days has been 8,622,561 shares. 2 times new highs have been achieved over the past 5 days, with a $0.0180 gain in that time frame. In the last twenty days, the average volume was 11,297,726, while in the previous 50 days, it was 4,962,872.
Since last month, TENX stock retreated -8.85%. Shares of the company fell to $0.0800 on 11/10/22, the lowest level in the past month. A 52-week high of $1.46 was reached on 01/04/22 after having rallying from a 52-week low of $0.08. Since the beginning of this year, TENX’s stock price has dropped by -86.73% or -$0.9020, and marked a new high 2 times. However, the stock has declined by -90.54% since its 52-week high.
Do You Own These 7 Inflation-Survival Stocks?
Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.
Click here to get your free copy of the report
In the three months ended June 29, Tenax Therapeutics Inc.’s quick ratio stood at 6.50, while its current ratio was 6.50, showing that the company is able to pay off its debt. Based on annual data, TENX earned $1000.0 in gross profit and brought in $32.73 million in revenue.
According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. While analysts expected Tenax Therapeutics Inc. to report -$0.09 quarterly earnings, the actual figure was -$0.11 per share, beating the consensus estimate by -22.20%. During the quarter, the company generated -$2.89 million in EBITDA. The liabilities of Tenax Therapeutics Inc. were 0.79 million at the end of its most recent quarter ended June 29, and its total debt was $0.33 million. The value of shareholders’ equity is $44.7 million.
This quick technical analysis looks at Tenax Therapeutics Inc.’s (TENX) price momentum. With a historical volatility rate of 247.00%, the RSI 9-day stood at 58.49% on 23 November.
With respect to its five-day moving average, the current Tenax Therapeutics Inc. price is up by +15.00% percent or $0.0180. At present, TENX shares trade +2.30% above its 20-day simple moving average and -55.54% percent below its 100-day simple moving average. However, the stock is currently trading approximately -40.95% below its SMA50 and -80.75% below its SMA200.
Stochastic coefficient K was 38.65% and Stochastic coefficient D was 35.13%, while ATR was 0.0288. Given the Stochastic reading of 51.56% for the 14-day period, the RSI (14) reading has been calculated as 53.00%.
Ladenburg Thalmann upgraded its rating on Tenax Therapeutics Inc. (NASDAQ: TENX) to a Buy in a note to investors on May 18, 2017. The analysts firm previously had a Neutral rating on the stock.Tenax Therapeutics Inc. (TENX) has been rated Buy by analysts. According to 0 brokerage firms, TENX is a sell, and 0 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Tenax Therapeutics Inc. stock as buy, with 1 recommending it as overweight.
With a median target price of $5.00, the current consensus forecast for the stock is $5.00 – $5.00. Based on these forecasts, analysts predict Tenax Therapeutics Inc. (TENX) will achieve an average price target of $5.00.